{
"@context": "https://schema.org",
"@type": "Article",
"headline": "Causation Split: First Circuit Pauses Teva Appeal; Regeneron Appeal Going Forward",
"url": "https://www.lexblog.com/2024/06/21/causation-split-first-circuit-teva-regeneron-appeal/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-703X6RE5",
"url": "https://www.lexblog.com/lib/703X6RE5/"
},
"datePublished": "2024-06-21T12:40:29-04:00",
"dateModified": "2024-06-21T09:40:55-04:00",
"author": {
"@type": "Person",
"name": "Brian Irving"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Bass, Berry & Sims PLC"
},
"organizationScope": "at-publication",
"isPartOf": "Inside the False Claims Act",
"about": "Government and Public Policy",
"sourceUrl": "https://www.insidethefalseclaimsact.com/?p=4095",
"sourceStability": "may-move"
}